Table 4 List of the serum samples along with the patient details.
Sl. no | Name of the samples | Age (in years) | Sex | Detection test (SA: Spleenic aspiration; BMA: Bone marrow aspiration) | Treatment status at the time of sample collection |
|---|---|---|---|---|---|
1 | VL1 | 4.5 | M | rK39 | Prior to treatment |
2 | VL2 | 45 | M | BMA | Miltefosine (Mil) & Sodium antimony gluconate (SAG) treated |
3 | VL3 | 25 | M | rK39, BMA | Prior to treatment |
4 | VL4 | 30 | M | rK39 | Prior to treatment |
5 | VL5 | 37 | M | BMA | Mil & SAG treated |
6 | VL6 | 1.5 | M | NA | Completed treatment |
7 | VL7 | 26 | M | NA | Relapse |
8 | VL8 | 21 | M | rK39, SA | Prior to treatment |
9 | VL9 | 24 | M | rK39 | Prior to treatment |
10 | VL10 | 25 | M | rK39, SA | Prior to treatment |
11 | VL11 | 14 | M | SA | Prior to treatment |
12 | VL12 | 45 | M | BMA | Mil & SAG treated |
13 | VL13 | 24 | M | rK39 | Relapse, Mil treated |
14 | VL14 | 15 | M | rK39 | Prior to treatment |
15 | VL15 | 62 | M | rK39, BMA | Completed treatment |
16 | VL16 | 60 | F | rK39, SA | Prior to treatment |
17 | VL17 | 13 | F | rK39 | Prior to treatment |
18 | VL18 | 19 | M | rK39 | Prior to treatment |
19 | VL19 | 18 | M | rK39 | Prior to treatment |
20 | VL20 | 45 | M | SA | Prior to treatment |
21 | PKDL1 | 16 | M | rK39 | PKDL cured |
22 | PKDL2 | 24 | F | rK39 | PKDL cured |
23 | PKDL3 | 19 | M | rK39 | PKDL cured |
24 | PKDL4 | 28 | M | rK39 | Prior to treatment |
25 | VL21 | 23 | F | rK39 | Prior to treatment |
26 | VL22 | 7 | Not recorded | rK39 | Prior to treatment |
27 | VL23 | 60 | M | rK39 | Prior to treatment |
28 | PKDL5 | 65 | M | rK39 | Prior to treatment |
